Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

4.06
-0.3400-7.73%
Pre-market: 4.160.0961+2.37%04:32 EDT
Volume:2.07M
Turnover:8.53M
Market Cap:390.95M
PE:-5.05
High:4.55
Open:4.55
Low:4.02
Close:4.40
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:2.45
T/O Rate:2.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8039
EPS(LYR):-0.9791
ROE:-81.73%
ROA:-48.74%
PB:3.35
PE(LYR):-4.15

Loading ...

Rezolute Says FDA Review Continues for Phase 3 sunRIZE Data on Ersodetug in Congenital Hyperinsulinism

Reuters
·
Yesterday

Rezolute, - Open-Label Extension Phase Ongoing with High Participation and Improved Glycemic Control

THOMSON REUTERS
·
Yesterday

Rezolute, - Enrollment Ongoing in Phase 3 Uplift Study for Tumor Hi; Results Expected Before End of 2026

THOMSON REUTERS
·
Yesterday

Rezolute, - FDA Still Reviewing Submission for Regulatory Path Forward for Ersodetug in Congenital Hi

THOMSON REUTERS
·
Yesterday

Rezolute Provides Update on FDA Review of Its Phase 3 Sunrize Study Results in Congenital Hyperinsulinism

THOMSON REUTERS
·
Yesterday

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 04

Rezolute Says Cash Position Totals $120 Million, Funds Operations into Mid-2028

Reuters
·
Aug 26

Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX)

TIPRANKS
·
Jul 30

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jul 14

Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar

Simply Wall St.
·
Jul 12

Rezolute Posts Corporate Deck on Phase 3 Ersodetug Program for Refractory Hypoglycemia in Hyperinsulinism

Reuters
·
Jun 27

Rezolute highlights Phase 3 sunRIZE data for ersodetug in congenital hyperinsulinism at ENDO meeting

Reuters
·
Jun 17

Rezolute Is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 15

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)

TIPRANKS
·
Jun 10

Craig-Hallum Keeps Their Hold Rating on Rezolute (RZLT)

TIPRANKS
·
Jun 05

Rezolute flags Phase 3 sunRIZE top-line results for ersodetug in congenital hyperinsulinism at ENDO 2026

Reuters
·
Jun 04

Rezolute Raised to Market Outperform From Market Perform by Citizens

Dow Jones
·
Jun 03

Wedbush Adjusts Price Target on Rezolute to $6 From $5, Maintains Outperform Rating

MT Newswires Live
·
Jun 03